Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Department of Health & Human Services OIG

QOL Medical and Its CEO Agree To Pay $47 Million for Allegedly Paying Kickbacks To Induce Claims for QOL's Drug Sucraid